Lupin Launches Clobetasol Propionate Spray in the US
Pharma major Lupin has announced the launch of its Clobetasol Propionate Spray 0.05% having received an approval from the United States Food and Drug Administration (FDA) earlier.
Lupin’s spray is the generic equivalent of Galderma Laboratories, L.P.’s Clobex Spray, 0.05%. It is indicated for the treatment of moderate to severe plaque psoriasis affecting up to 20% body surface area (BSA) in patients 18 years of age or older.
The spray 0.05% had annual sales of approximately $30.5-mn in the US (IQVIA MAT January 2018).
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$1.8E+2/UNIT FOB
2026-08-12
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
First New UV Filter in Nearly 27 Years: BASF's Tinosorb® S Approved by FDA, Marking a Historic Shift for the U.S. Sunscreen Market
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
FDA delays proposal to ban formaldehyde in hair straighteners
-
Can Florida's Authorization to Import Prescription Drugs from Canada Lower Medication Prices?
-
FDA Releases New Resources for Food Traceability Final Rule Compliance
-
IFSAC Unveils 2021 Report: Diverse Food Sources Linked to Salmonellosis Cases
-
FDA to Nationwide Ban Brominated Vegetable Oil (BVO) in Food
-
FDA Issues Warning to Produce Importer for Non-Compliance
-
FDA Proposes Ban on Hair Relaxers Containing Formaldehyde
Recommend Reading
-
India’s Tariff Cuts Could Lower Agrochemical Costs
-
FDA Dye Tracker Raises Reformulation Pressure Across Food Brands
-
FDA Tightens the Solvent Side of Natural Color Production
-
Thymol Gel Wins EPA Approval for Beekeepers
-
FSANZ Moves Toward Approval of Insect-Resistant Corn COR121
-
In October, the Chinese acetic acid market showed a weak downward trend
-
Supply Surplus Expectations Increase, Brent Crude Falls Below $60
-
Cost Support Struggles to Cope with Flat Demand—Melamine Prices Remain Stabilized at High Levels
-
Demand Weakens, Butanol Prices Retreat from High Levels
-
Raw Material Support Drives Uptick in Adipic Acid Prices